¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"T4"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
18
ÄÚµå
¿µ¹®
ÇѱÛ
T43
Poisoning by psychotropic drugs, NEC
´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº Á¤½ÅÀÛ¿ë ¾à¹°¿¡ ÀÇÇÑ Áßµ¶
T49
Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolaryngological and dental drugs
ÀÏÂ÷ÀûÀ¸·Î ÇǺΠ¹× Á¡¸·¿¡ ¿µÇâÀ» ÁÖ´Â ±¹¼ÒÀû ¾à¹° ¹× ¾È°ú, À̺ñÀÎÈİú ¹×Ä¡°úÀû ¾à¹°¿¡ ÀÇÇÑ Áßµ¶
T44.4
Predominantly ¥á-adrenoreceptor agonists, NEC
´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ÁÖ·Î ¾ËÆÄ¾Æµå·¹³¯¸° ¼ö¿ëü È¿´ÉÁ¦
T44.5
Predominantly ¥â-adrenoreceptor agonists, NEC
´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ÁÖ·Î º£Å¸¾Æµå·¹³¯¸° ¼ö¿ëü È¿´ÉÁ¦
T45.9
Primarily systemic and haematological agent, unspecified
»ó¼¼ºÒ¸íÀÇ ÀÏÂ÷ÀûÀ¸·Î Àü½Å ¹× Ç÷¾×ÇÐÀû ¾à¹°
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½